tk88 bet

Regional experience in ARV treatment investment shared

The antiretroviral (ARV) treatment for HIV/AIDS patients has been a focused investment in numerous countries thanks to its efficiency.
The antiretroviral (ARV) treatment for HIV/AIDS patients has been afocused investment in numerous countries thanks to its efficiency.

Statistics showed that in 2010, Thailand provided ARV treatmentfor 70 percent of over 350,000 patients with HIV. A year later, thecountry allocated 330 million USD from its State budget for HIV/AIDSprevention and control, 73 percent of which was spent on ARV medication.

Meanwhile, in 2012, Malaysia enabled 38.5percent of 80,000 HIV carriers to have access to ARV treatment, whichcost 20.4 million USD, mainly sourced from its State budget. Since 2011,assistance from the Global Fund accounted for less than five percent ofthe country’s treatment costs.

Indonesia,whose average per capita income falls below 1,000 USD, much lower thanthat of Vietnam, has provided free check-ups and treatment for HIVcarriers. Since 2005, the country has offered free services throughincreasing allocations from the state budget to meet the demand.

In Vietnam, in 2010-2014, thecost for HIV/AIDS prevention and control was financed mainly byinternational donors, with the biggest ones being the Global Fund andthe US President’s Emergency Plan for AIDS Relief (PEPFAR). TheState budget accounted for about five percent of the total sum.

However, donor funding has been transitioning to other areas in theregion, leaving substantial gaps in intervention programming resources.For 2015, government funded resources have been raised to 85 billion VND(4 million USD), but it remains insufficient to cover the gap left byinternational funding departures.

According tothe World Health Organisation (WHO), the use of ARV therapy,particularly in the early stage of the disease, can lead to substantialreductions in the rates of death and suffering.

ARV treatment has also been proven to reduce the rate of new infectionsto below 2-4 percent while easing the financial burden for familieswith HIV/AIDS patients.

Since 2013, the WHOhas recommended the treatment for preventing HIV infection, particularlyfor pregnant women, young children, and at-risk populations exposed toHIV.

As of September, 2014, Vietnam had 220,000 HIV cases and nearly 70,000 fatalities.-VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

Forum spotlights𒆙 AI and digital innovation in hea♈lthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

S☂harp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

Vietnam, France collaborate in vaccine production technology trཧansfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Medical facilities have been instructed to prepare necessary infrastructure, medical equipment, and supplies to ensure effective patient admission, isolation, diagnosis, treatment, and infection control. - Illustrative image (Photo: VNA)

Enhanced anti-COVID-19 measures in placeꦛ amid rising cases

According to the World Health Organisation, more than 25,000 COVID-19 cases have been recorded globally over the past month. Notably, from January 1 to May 10, Thailand reported nearly 54,000 infections and 16 deaths. The rise in cases in Thailand has been linked to the spread of XBB.1.16 subvariant.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|